Literature DB >> 8094924

Current pathogenetic and molecular concepts in viral liver carcinogenesis.

P Schirmacher1, C E Rogler, H P Dienes.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most frequent malignancies in humans and in most cases a consequence of chronic infection of the liver by hepatotropic viruses (Hepatitis B Virus (HBV) and possibly Hepatitis C Virus (HCV)). Formation of HCC results from a stepwise process involving different preneoplastic lesions that reflect multiple genetic events, like protooncogene activation, tumor suppressor gene inactivation, and growth factor over- or reexpression. Recent investigations have gained new insights into how these factors are activated and may interact. In addition, improved knowledge of the molecular biology of HBV has led to better understanding of its pleiotropic effects on induction and progression in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094924     DOI: 10.1007/bf02899246

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  9 in total

1.  The facultative stem cell: A new star in liver pathology.

Authors:  Peter Nagy
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

2.  Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.

Authors:  Chao-Hung Hung; Jing-Houng Wang; Tsung-Hui Hu; Chien-Hung Chen; Kuo-Chin Chang; Yi-Hao Yen; Yuan-Hung Kuo; Ming-Chao Tsai; Sheng-Nan Lu; Chuan-Mo Lee
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

3.  Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis.

Authors:  D Nehrbass; F Klimek; P Bannasch
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 4.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus.

Authors:  A Puisieux; J Ji; C Guillot; Y Legros; T Soussi; K Isselbacher; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.

Authors:  J F Tsai; J E Jeng; M S Ho; W Y Chang; M Y Hsieh; Z Y Lin; J H Tsai
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

7.  Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.

Authors:  S Kubo; S Nishiguchi; T Shuto; H Tanaka; T Tsukamoto; K Hirohashi; T Ikebe; K Wakasa; T Kuroki; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  1999-02

8.  [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology].

Authors:  M A Kern; K Breuhahn; M Schuchmann; P Schirmacher
Journal:  Pathologe       Date:  2007-07       Impact factor: 0.973

Review 9.  Involvement of DNA damage response pathways in hepatocellular carcinoma.

Authors:  Sheau-Fang Yang; Chien-Wei Chang; Ren-Jie Wei; Yow-Ling Shiue; Shen-Nien Wang; Yao-Tsung Yeh
Journal:  Biomed Res Int       Date:  2014-04-28       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.